Lord Rennard – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Lord Rennard on 2016-10-21.
To ask Her Majesty’s Government, further to the statement by Baroness Chisholm of Owlpen on 20 October (HL Deb, col 2484–90), how much of the Pharmacy Access Fund will come from existing funds to support community pharmacies, and how much of the Pharmacy Access Fund will be additional money to support community pharmacies.
Lord Prior of Brampton
The Pharmacy Access Scheme (PhAS) will be paid for from the funding for the community pharmacy contractual framework. The PhAS will be an additional monthly payment, made to all small and medium sized pharmacies that are a mile or more from another pharmacy. The PhAS has been designed to capture the pharmacies that are most important for patient access, specifically those pharmacies where patient and public access would be materially affected should they close. The PhAS takes isolation and need levels into account.
The scheme also includes a review process, and reviews of eligibility will also be granted for pharmacies that may have narrowly missed out on the scheme through the distance criteria, but are in areas of high deprivation. This will cover pharmacies that are located in the top 20% most deprived areas in England, and are located 0.8 miles or more from another pharmacy. Additional funding for successful reviews under this criterion will be made available as required.
